Clinical trials can be stopped early for a range of reasons. But when that happens, it can be tricky to interpret the results and to understand the reasons why the trial was stopped in the first place. Join us in this episode of Curbside Consults with Dr. David Harrington, statistical editor at the NEJM, as we discuss...

Statistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David Harrington

This podcast from NEJM Resident 360 takes a deep dive into key topics with expert clinicians and educators. As we explore the details of pathophysiology and critique the evidence behind clinical practice, these conversations are intended to give you better understanding of the topic and greater confidence when treating your patients.

Share Statistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David Harrington

Sign up to save your podcasts

Statistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David Harrington

Statistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David Harrington

More shows like Curbside Consults

NEJM This Week

NEJM Interviews

JAMA Clinical Reviews

Clinical Conversations

Leadership Conversations

NEJM AI Grand Rounds

Intention to Treat

Not Otherwise Specified